Home > Publications Database > The relationship between depressive symptoms and restless legs syndrome in two prospective cohort studies. > print

001     137231
005     20240321220220.0
024 7 _ |a 10.1097/PSY.0b013e31828bbbf1
|2 doi
024 7 _ |a pmid:23576767
|2 pmid
024 7 _ |a 0033-3174
|2 ISSN
024 7 _ |a 1534-7796
|2 ISSN
024 7 _ |a altmetric:1384700
|2 altmetric
037 _ _ |a DZNE-2020-03553
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Szentkiralyi, Andras
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a The relationship between depressive symptoms and restless legs syndrome in two prospective cohort studies.
260 _ _ |a Philadelphia, Pa.
|c 2013
|b Lippincott Williams & Wilkins
264 _ 1 |3 print
|2 Crossref
|b Ovid Technologies (Wolters Kluwer Health)
|c 2013-05-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1585562190_22217
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Cross-sectional studies suggest a strong association between depression and restless legs syndrome (RLS); however, the temporal relationship between the two disorders remains unknown. We tested whether the presence of clinically relevant depressive symptoms (CRDS) is a risk factor for subsequent RLS in the general population. The relationship between prevalent RLS and incident CRDS was also examined.Two independent, prospective cohort studies with representative, age-stratified random samples, the Dortmund Health Study (DHS; n = 1312/1122 [baseline/follow-up], median follow-up time = 2.1 years) and the Study of Health in Pomerania (SHIP; n = 4308/3300, median follow-up time = 5.0 years) were analyzed. RLS was assessed in both studies according to the RLS minimal criteria, at baseline and at follow-up. CRDS were assessed by the Center for Epidemiologic Studies-Depression scale (a score of ≥16) in DHS only at baseline and by the Munich-Composite International Diagnostic-Screener in SHIP at baseline and at follow-up.Clinically relevant depressive symptoms at baseline were associated new-onset RLS in both studies (DHS: odds ratio [OR] = 1.94, 95% confidence interval [CI] = 1.09-3.44; SHIP: OR = 2.37, 95% CI = 1.65-3.40) after adjustment for age, sex, education, body mass index, smoking, physical activity, and the presence of various comorbidities. RLS at baseline was an independent risk factor of incident CRDS in SHIP (OR = 1.82, 95% CI = 1.10-3.00).The presence of CRDS may be a risk factor for subsequent RLS. The relationship between the two disorders might be bidirectional because RLS also predicts incident depressive symptoms.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Comorbidity
|2 MeSH
650 _ 2 |a Depression: epidemiology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Follow-Up Studies
|2 MeSH
650 _ 2 |a Germany: epidemiology
|2 MeSH
650 _ 2 |a Health Surveys
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Incidence
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Motor Activity
|2 MeSH
650 _ 2 |a Obesity: epidemiology
|2 MeSH
650 _ 2 |a Prevalence
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Restless Legs Syndrome: epidemiology
|2 MeSH
650 _ 2 |a Restless Legs Syndrome: psychology
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
650 _ 2 |a Sampling Studies
|2 MeSH
650 _ 2 |a Smoking: epidemiology
|2 MeSH
650 _ 2 |a Surveys and Questionnaires
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
700 1 _ |a Völzke, Henry
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Hoffmann, Wolfgang
|0 P:(DE-2719)2000040
|b 2
|u dzne
700 1 _ |a Baune, Bernhard T
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Berger, Klaus
|0 P:(DE-HGF)0
|b 4
773 1 8 |a 10.1097/psy.0b013e31828bbbf1
|b : Ovid Technologies (Wolters Kluwer Health), 2013-05-01
|n 4
|p 359-365
|3 journal-article
|2 Crossref
|t Psychosomatic Medicine
|v 75
|y 2013
|x 0033-3174
773 _ _ |a 10.1097/PSY.0b013e31828bbbf1
|g Vol. 75, no. 4, p. 359 - 365
|0 PERI:(DE-600)2054116-8
|n 4
|q 75:4<359 - 365
|p 359-365
|t Psychosomatic medicine
|v 75
|y 2013
|x 0033-3174
909 C O |o oai:pub.dzne.de:137231
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2000040
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2013
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PSYCHOSOM MED : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-2719)1510600
|k Translational Health Care Research
|l Translational Health Care Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1510600
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21